STOCK TITAN

Xylo Technologies - XYLO STOCK NEWS

Welcome to our dedicated page for Xylo Technologies news (Ticker: XYLO), a resource for investors and traders seeking the latest updates and insights on Xylo Technologies stock.

Overview of Xylo Technologies Ltd

Xylo Technologies Ltd (XYLO) is an Israel-based technology company that excels in the development, manufacturing, and marketing of innovative direct vision systems for minimally invasive medical procedures, along with advanced safety systems for drones and the electric vehicle (EV) market. By leveraging proprietary platform technology, Xylo has engineered breakthrough solutions such as the MUSE (Medigus Ultrasonic Surgical Endostapler) system, a single-use device designed for incision-less treatment of gastroesophageal reflux disease (GERD). This pioneering product is built on advanced ultrasonic and surgical principles, reflecting the company’s depth in medical device innovation.

Core Business Segments and Technological Focus

Xylo Technologies operates across multiple strategic business segments. In the advanced medical solutions arena, the company focuses on direct vision and minimally invasive procedures, where its platform technology has significantly improved patient outcomes, providing safer, more efficient treatment options for complex conditions. Additionally, Xylo extends its technological expertise into digital commerce through affiliations with companies active in e-commerce, online advertising, and internet traffic routing. This diversification underscores its commitment not only to medical innovation but also to harnessing digital trends in commerce.

Another critical focus area for Xylo is the electric vehicle (EV) sector. Through partnerships and strategic affiliations, the company has established a presence in the EV market, primarily by developing and integrating advanced safety systems and related robotics solutions. Xylo’s involvement in safety systems extends to the design of components for drones and related autonomous technology, a field that demands precision engineering and robust safety features. The company’s technology is grounded in reliable and tested principles, making it a noteworthy contributor in multiple evolving industries.

Market Position and Competitive Landscape

Positioned at the intersection of medical technology and digital innovation, Xylo Technologies has carved out a distinctive niche in its competitive landscape. The company’s approach is built around strategic growth partnerships and affiliations, including investments in firms that advance robust solutions in robotics, artificial intelligence, and digital event management. Such a diversified strategy allows Xylo to mitigate risks by balancing core medical device offerings with emerging digital and electronic mobility trends. This multi-sector integration distinguishes Xylo from competitors that may focus narrowly on one segment of the market.

Technology and Innovation

The heart of Xylo’s innovation lies in its ability to integrate high-precision medical device engineering with digital technology solutions. Its proprietary development process is underpinned by decades of specialized expertise, resulting in products that are not only safe and effective but also tailored to address the specific needs of clinicians and patients. In the realm of digital commerce, Xylo has made strategic moves by establishing technology platforms that streamline online advertising, event management, and corporate solutions, thereby reaffirming its role as a forward-thinking technology partner in multiple sectors.

Geographical Reach and Strategic Partnerships

Xylo Technologies maintains a broad geographical footprint, serving markets across the United States, Europe, Great Britain, Israel, Canada, Asia, and beyond. Its global presence is reinforced by a network of partnerships and affiliates that support its expansive operational model, ensuring that its innovative solutions meet diverse regulatory standards and market expectations worldwide. These alliances enhance Xylo's capacity to deliver high-quality solutions that resonate with both local and international market demands.

Company Affiliations and Ecosystem

In addition to its core products, Xylo’s portfolio is enriched by a range of strategic affiliations. The company holds interests in various technology solution providers, spanning advanced medical platforms, digital commerce engines, and electric vehicle-associated safety systems. This ecosystem approach not only creates synergies among its different business units but also exemplifies its commitment to comprehensive innovation. The integration of autonomous robotics solutions and AI-driven platforms further illustrates its proactive approach to embracing new technological frontiers, making Xylo a multifaceted player in today’s rapidly evolving tech landscape.

Conclusion

Overall, Xylo Technologies Ltd stands out as a technology company that masterfully combines expertise in advanced medical devices with robust digital commerce and EV safety solutions. Its focus on minimally invasive procedures, strategic diversification, and global operational scope provide a well-rounded picture of a company that is as committed to innovation as it is to meeting the practical demands of modern healthcare and digital commerce markets. Investors and analysts seeking to understand the interplay between technology-driven innovation and diversified market strategies will find Xylo Technologies a compelling case of integrated industry expertise.

Rhea-AI Summary

Xylo Technologies announced that Revoltz has received approval from the Israeli Standards Institute to sell its PORTO EV micro vehicle in Israel. Revoltz is 19.9% owned by Charging Robotics (63.7% owned by Xylo). The Standard 6230 Type Approval allows riders as young as 16 to operate the vehicle without a driver's license.

The PORTO EV, designed for last-mile delivery, offers storage capacity similar to a small hatchback car and can operate for a full day on a single charge. In 2023, Revoltz secured a $2.7 million exclusive distribution agreement in Israel, with an initial purchase of 50 PORTO units and a commitment for 150 vehicles in the first year. The five-year agreement includes annual milestones and service provisions, primarily targeting the local delivery market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.31%
Tags
none
-
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) announced that ParaZero Technologies (Nasdaq: PRZO), an aerospace company 18.68% owned by Xylo, has initiated a partnership with a leading Tier 1 defense OEM to adapt its drone safety systems for military and medical missions. ParaZero received an initial order for 50 systems for testing, with plans to develop adaptations for medical delivery systems. Upon successful testing, the customer intends to purchase hundreds more systems for a pilot program. The project aims to enhance medical field mission deliveries in critical and remote areas, with completion expected by the end of 2024. ParaZero's goal is to develop a scalable, cost-effective mass production system for wider deployment, potentially entering defense markets and improving healthcare logistics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.07%
Tags
none
-
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) has announced that Revoltz , 19.9% owned by Charging Robotics, Inc. (OTC: CHEV), is developing a new three-wheel electric cargo bike for European and UK markets. The bike features:

  • Enhanced stability and increased payload capacity
  • Advanced full-tilting suspension system
  • Compliance with European and UK regulatory standards
  • Pedal and electric motor combination for efficient, eco-friendly rides
  • Versatile configurations for various transportation needs

The prototype is expected within three months, with commercialization anticipated for early 2025. This innovative product aims to address urban transportation challenges and promote sustainable mobility solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.98%
Tags
none
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) has announced a planned reverse split of its American Depositary Receipt (ADR) program. The ratio change will be 1 new ADS for every 2.666666 old ADSs. Each new ADS will represent 40 ordinary shares, up from the previous 15. The effective date is set for August 5, 2024. Xylo's ADSs will continue trading on Nasdaq under the symbol 'XYLO' with a new CUSIP Number. ADS holders must surrender their old ADSs to BNY Mellon for cancellation. The change will not affect the company's ordinary shares or alter shareholders' ownership percentages, except for minor adjustments due to fractional ADSs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
none
-
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) announced that its subsidiary, Charging Robotics, Inc. (OTC: CHEV), received its first commercial order for wireless charging systems in automatic parking facilities. The order, from Parking Design , is for 12 systems to be delivered throughout 2025. This follows a pilot project in Tel Aviv, Israel.

Charging Robotics' system uses machine learning and AI to manage EV charging efficiently, prioritizing based on factors like departure time and vehicle type. This technology addresses increasing electricity demand in parking facilities. The collaboration aims to revolutionize EV management and charging in automated parking environments, focusing on sustainability and operational excellence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.52%
Tags
none
-
Rhea-AI Summary

Xylo Technologies announces that Charging Robotics, a company it owns a 67% stake in, has received its first commercial order for its wireless EV charging systems from Parking Design. This order entails the deployment of 12 systems in automatic parking facilities, to be fulfilled throughout 2025. The wireless charging system uses AI and machine learning to optimize EV charging, ensuring efficient and prioritized energy distribution. This innovation aims to enhance the convenience and sustainability of automated parking solutions. A pilot project was recently completed in Tel Aviv, marking a significant milestone in their collaboration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
none
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) announced that its subsidiary Gix Internet (45.75% owned by Xylo, TASE: GIX) signed a non-binding MOU with a robotics company specializing in AI autonomous robotics for medical logistics. The MOU outlines a share exchange transaction, where the robotics company will become a wholly-owned subsidiary of Gix. The completion of this transaction is expected to provide Gix with growth opportunities and technological advancements in AI and robotics. Shareholders of the robotics company will receive 30% of Gix's ordinary shares, with options to increase holdings to 37.5% and 45% upon meeting specific commercial milestones.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.06%
Tags
-
Rhea-AI Summary

Xylo Technologies announced that its 19.99% owned subsidiary, Metagramm Software, completed the development of Bubbl, an advanced AI-powered writing tool. Bubbl employs Machine Learning, Natural Language Processing, and Deep Learning to offer personalized text writing and rewriting, setting it apart from other AI tools. The tool features a clean design and various user modes, including interactive re-write and grammar-only modes. It supports multiple writing profiles, such as Business, Medical, Academic, and Blogging, each with tailored assistance. Bubbl will launch for select users in Q3 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
AI
-
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) has signed a letter of intent (LOI) to acquire a leading AI technology company based in Germany. This acquisition aims to expand Xylo's portfolio into advanced AI technologies such as predictive maintenance and condition monitoring. The target company has been a European leader for over a decade, providing AI and machine learning solutions to various global industries including aerospace, aviation, transportation, real estate, and security. Xylo will make a down payment of 1.5 million Euros and initially acquire 51% of the target company's shares, with the remaining 49% contingent on the company's 2024 EBITDA results. This strategic move was facilitated by Xylo's newly appointed senior advisor, an expert in AI with a distinguished career in both academia and industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.9%
Tags
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) announced that Charging Robotics (OTC: FDOCD), 67% owned by Xylo, in collaboration with Make My Day, has reached the final development stage of an AI-based EV charging management system.

This system addresses the challenge of insufficient electricity supply for EV charging in automatic car parks by using machine learning algorithms to prioritize and optimize charging sequences based on parameters such as departure time, vehicle type, and driving style.

The system integrates seamlessly with Charging Robotics’ wireless charging setup and was recently piloted in Tel Aviv, Israel.

CEO Hovav Gilan emphasized the value this feature adds for future customers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.88%
Tags
AI

FAQ

What is the current stock price of Xylo Technologies (XYLO)?

The current stock price of Xylo Technologies (XYLO) is $4.85 as of April 4, 2025.

What is the market cap of Xylo Technologies (XYLO)?

The market cap of Xylo Technologies (XYLO) is approximately 3.9M.

What is the core business of Xylo Technologies Ltd?

Xylo Technologies is focused on developing innovative medical devices, including direct vision systems for minimally invasive procedures, as well as safety systems for drones and the electric vehicle sector.

In which industries does Xylo Technologies operate?

The company operates in advanced medical solutions, digital commerce, and the electric vehicle market, integrating technology across healthcare, online platforms, and mobility sectors.

What is the significance of the MUSE system?

The MUSE system is a single-use, incision-less device designed for the treatment of gastroesophageal reflux disease, showcasing Xylo's capability in advancing minimally invasive surgical technologies.

How does Xylo Technologies generate value?

Xylo leverages proprietary technology and strategic partnerships to innovate across multiple sectors, offering diversified revenue streams from its medical device products and digital commerce solutions.

What strategic partnerships does Xylo engage in?

Xylo maintains affiliations with companies in robotics, artificial intelligence, digital advertising, and event management, thereby building an ecosystem that enhances its technological capabilities and market reach.

How has the company diversified its operations?

Beyond medical devices, Xylo has expanded its portfolio to include digital commerce platforms and EV safety solutions, ensuring a balanced approach to technological innovation across different market segments.

What geographical markets does Xylo Technologies serve?

The company has established a presence in key regions including the United States, Europe, Great Britain, Israel, Canada, and Asia, reflecting its commitment to a global operational footprint.

How does Xylo maintain its industry expertise?

Through continuous investment in research and development, strategic growth partnerships, and a diversified portfolio, Xylo consistently demonstrates high-level expertise in medical technology, digital platforms, and safety systems.
Xylo Technologies

Nasdaq:XYLO

XYLO Rankings

XYLO Stock Data

3.87M
659.57k
9.9%
7.95%
0.72%
Medical Devices
Healthcare
Link
Israel
Tel Aviv